Mary Miller Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 34.6K

2.88% 3M change

8.92% 12M change

Total Value Held N/A

Mary Miller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2025	SELL Payment of exercise price or tax liability	$412 $2.24 p/Share	184 Reduced 0.53%	34,555 Common Stock
Oct 17 2025	SELL Payment of exercise price or tax liability	$1,009 $1.81 p/Share	558 Reduced 1.58%	34,739 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$514 $1.81 p/Share	284 Reduced 0.8%	35,297 Common Stock
Aug 14 2025	SELL Payment of exercise price or tax liability	$255 $1.39 p/Share	184 Reduced 0.51%	35,581 Common Stock
Jul 17 2025	SELL Payment of exercise price or tax liability	$736 $1.32 p/Share	558 Reduced 1.54%	35,765 Common Stock
May 14 2025	SELL Payment of exercise price or tax liability	$209 $1.14 p/Share	184 Reduced 0.5%	36,323 Common Stock
Apr 17 2025	SELL Payment of exercise price or tax liability	$1,009 $1.81 p/Share	558 Reduced 1.51%	36,507 Common Stock

Feb 14 2025	SELL Payment of exercise price or tax liability	$1,176 $5.42 p/Share	217 Reduced 0.58%	37,065 Common Stock
Jan 17 2025	SELL Payment of exercise price or tax liability	$3,809 $5.78 p/Share	659 Reduced 1.74%	37,282 Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$1,457 $7.92 p/Share	184 Reduced 0.48%	37,941 Common Stock
Oct 17 2024	SELL Payment of exercise price or tax liability	$4,391 $7.87 p/Share	558 Reduced 1.44%	38,125 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$1,982 $6.98 p/Share	284 Reduced 0.73%	38,683 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$1,291 $7.02 p/Share	184 Reduced 0.47%	38,967 Common Stock
Jul 17 2024	SELL Payment of exercise price or tax liability	$4,291 $7.69 p/Share	558 Reduced 1.41%	39,151 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$1,538 $8.36 p/Share	184 Reduced 0.46%	39,709 Common Stock
Apr 17 2024	SELL Payment of exercise price or tax liability	$5,769 $10.34 p/Share	558 Reduced 1.38%	39,893 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$737 $3.4 p/Share	217 Reduced 0.53%	40,451 Common Stock
Jan 17 2024	SELL Payment of exercise price or tax liability	$2,836 $4.35 p/Share	652 Reduced 1.58%	40,668 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$3,733 $5.08 p/Share	735 Reduced 1.75%	41,320 Common Stock
Oct 17 2023	SELL Payment of exercise price or tax liability	$12,231 $5.48 p/Share	2,232 Reduced 5.04%	42,055 Common Stock
Sep 26 2023	BUY Grant, award, or other acquisition	-	3,858 Added 8.01%	44,287 Common Stock

Also insider at

BFLY

Butterfly Network, Inc. Healthcare

General Counsel & Corp Sec

Mary Miller

Chief Legal Officer

Guilford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Acrivon Therapeutics, Inc.

Track Activities on ACRV

Account